Low-dose chymotrypsin treatment inhibits neutrophil migration into sites of inflammation in vivo: Effects on Mac-1 and MEL-14 adhesion protein expression and function
- 1 January 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 132 (1) , 201-214
- https://doi.org/10.1016/0008-8749(91)90019-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mouse Lymph Node Homing Receptor cDNA Clone Encodes a Glycoprotein Revealing Tandem Interaction DomainsScience, 1989
- Endothelial Leukocyte Adhesion Molecule 1: an Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and LectinsScience, 1989
- Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.Journal of Clinical Investigation, 1988
- The Pi-linked receptor FcRIII is released on stimulation of neutrophilsNature, 1988
- Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium.Journal of Clinical Investigation, 1988
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988
- Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation.Journal of Clinical Investigation, 1987
- Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.Journal of Clinical Investigation, 1985
- A cell-surface molecule involved in organ-specific homing of lymphocytesNature, 1983
- Mac‐1: a macrophage differentiation antigen identified by monoclonal antibodyEuropean Journal of Immunology, 1979